A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

NCT07242248 · clinicaltrials.gov ↗

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease
Colitis, Ulcerative
Crohn's Disease

Sponsor

Janssen-Cilag Ltd.